193 related articles for article (PubMed ID: 16611203)
1. Chemoprevention in gastrointestinal cancers: current status.
Grau MV; Rees JR; Baron JA
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):281-7. PubMed ID: 16611203
[TBL] [Abstract][Full Text] [Related]
2. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular carcinoma by immunization against hepatitis B.
Zuckerman AJ
Int Rev Exp Pathol; 1985; 27():59-81. PubMed ID: 3017884
[No Abstract] [Full Text] [Related]
4. Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
Baron JA
Prog Exp Tumor Res; 2003; 37():1-24. PubMed ID: 12795046
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers.
Morgan G
Gut; 1996 May; 38(5):646-8. PubMed ID: 8707106
[No Abstract] [Full Text] [Related]
7. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus and the control of hepatocellular carcinoma.
Blumberg BS
IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
[TBL] [Abstract][Full Text] [Related]
10. Prevention of primary liver cancer.
Oon CJ
Ann Acad Med Singap; 1984 Apr; 13(2):190-3. PubMed ID: 6093675
[TBL] [Abstract][Full Text] [Related]
11. From hepatitis to hepatoma: lessons from type B viral hepatitis.
Chen DS
Science; 1993 Oct; 262(5132):369-70. PubMed ID: 8211155
[No Abstract] [Full Text] [Related]
12. Hepatitis B virus and the prevention of primary cancer of the liver.
Blumberg BS; London WT
J Natl Cancer Inst; 1985 Feb; 74(2):267-73. PubMed ID: 2983134
[No Abstract] [Full Text] [Related]
13. Causes of and prevention strategies for hepatocellular carcinoma.
Cabibbo G; Maida M; Genco C; Antonucci M; Cammà C
Semin Oncol; 2012 Aug; 39(4):374-83. PubMed ID: 22846856
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.
Chang MH
Clin Liver Dis; 2010 Aug; 14(3):521-30. PubMed ID: 20638029
[TBL] [Abstract][Full Text] [Related]
15. Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine.
Tsai HJ
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):112-5. PubMed ID: 25951712
[TBL] [Abstract][Full Text] [Related]
16. Vaccines: taking a shot at protection.
Weintraub K
Nature; 2014 Dec; 516(7529):S12-3. PubMed ID: 25470194
[No Abstract] [Full Text] [Related]
17. Report of the OAU/STRC Ad Hoc Committee on Hepatitis B Vaccination in Africa.
IARC Sci Publ; 1984; (63):393-401. PubMed ID: 6100277
[No Abstract] [Full Text] [Related]
18. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
[TBL] [Abstract][Full Text] [Related]
19. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
[TBL] [Abstract][Full Text] [Related]
20. Prevention of primary liver cancer by immunization.
Zuckerman AJ
N Engl J Med; 1997 Jun; 336(26):1906-7. PubMed ID: 9197221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
